Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan

Chanroth Chhoung,Ko Ko,Serge Ouoba,Zayar Phyo,Golda Ataa Akuffo,Aya Sugiyama,Tomoyuki Akita,Hiroshi Sasaki,Tadashi Yamamoto,Kazuaki Takahashi,Junko Tanaka
DOI: https://doi.org/10.1186/s12864-024-10973-0
IF: 4.547
2024-11-13
BMC Genomics
Abstract:The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persists, giving rise to new variants characterized by mutations in the spike protein. However, public data regarding the virus's evolutionary trend is not widely available after the downgrade of coronavirus disease 2019(COVID-19). Therefore, this study aimed to investigate the applicability of an in-house Sanger-based method for identifying SARS-CoV-2 variants, particularly focusing on newly emerged Omicron variants, and updating the epidemiology of COVID-19 during the 8 th wave in Hiroshima Prefecture.
genetics & heredity,biotechnology & applied microbiology
What problem does this paper attempt to address?